CGNH — CardioGenics Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for CardioGenics Holdings, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	C2011 October 31st	2012 October 31st	2013 October 31st	2014 October 31st	2015 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.009	0.001	0	0	0
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	5.66	1.32	2.53	0.974	0.772
Operating Profit	-5.65	-1.31	-2.53	-0.974	-0.772
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-5.76	-1.32	-2.94	-2.68	-1.92
Provision for Income Taxes
Net Income After Taxes	-5.76	-1.32	-2.94	-2.68	-1.92
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-5.72	-1.31	-2.92	-2.68	-1.92
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-5.72	-1.31	-2.92	-2.68	-1.92
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.072	-0.023	-0.048	-0.043	-0.02
Dividends per Share